| RS2537139887 |
CFAP418
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 16, Retinal dystrophy |
| RS2537141455 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS2537142167 |
KIF1A
|
Health Risk |
Likely pathogenic |
KIF1A-related disorder, KIF1A-related disorder |
| RS2537149434 |
CFAP418
|
Health Risk |
Pathogenic |
— |
| RS2537162620 |
DST
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2537169914 |
DST
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2537182031 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS2537182158 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS2537186945 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS2537193194 |
PEX3
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2537193288 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nicolaides-Baraitser syndrome |
| RS2537194228 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537195567 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537196651 |
PEX3
|
Health Risk |
Likely pathogenic |
— |
| RS2537196715 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS2537199055 |
PEX3
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2537199126 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS2537205726 |
EYA1
|
Health Risk |
Likely pathogenic |
Otofaciocervical syndrome 1, Otofaciocervical syndrome 1 |
| RS2537208023 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537208469 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |
| RS2537209067 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537209124 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 1, Branchiootic syndrome 1 |
| RS2537251153 |
SLC52A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2537254905 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
— |
| RS2537257570 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537260421 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS2537260821 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537261082 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537261425 |
FGFR1
|
Health Risk |
Pathogenic |
Pfeiffer syndrome, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537262005 |
FGFR1
|
Health Risk |
Likely pathogenic |
FGFR1-related disorder, FGFR1-related disorder |
| RS2537262217 |
MPIG6B
|
Health Risk |
Pathogenic |
— |
| RS2537263906 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS2537268171 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537271517 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS2537272542 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS2537273757 |
MPIG6B
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, anemia |
| RS2537273857 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Fraser syndrome, Branchiootorenal syndrome 1 |
| RS2537274008 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537274013 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537274059 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS2537274064 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537274178 |
MPIG6B
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, anemia |
| RS2537274368 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537274535 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537274612 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537274776 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Branchiootic syndrome 1 |
| RS2537276188 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537276269 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537276482 |
TYRP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocutaneous albinism type 3, MELANESIAN BLOND HAIR |
| RS2537277627 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2537278093 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blepharophimosis-impaired intellectual development syndrome, Blepharophimosis-impaired intellectual development syndrome |
| RS2537279998 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537280344 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537280352 |
EYA1
|
Health Risk |
Likely pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537283301 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537283697 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537283743 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537284365 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537284941 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS2537284977 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537288712 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS2537289969 |
WASHC5
|
Health Risk |
Likely pathogenic |
Ritscher-Schinzel syndrome 1, Ritscher-Schinzel syndrome 1 |
| RS2537292932 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS2537293281 |
TYRP1
|
Health Risk |
Likely pathogenic |
— |
| RS2537293282 |
TYRP1
|
Health Risk |
Likely pathogenic |
— |
| RS2537295426 |
RAD21
|
Health Risk |
Likely pathogenic |
RAD21-related disorder, RAD21-related disorder |
| RS2537296864 |
PLEC
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex with nail dystrophy |
| RS2537297433 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, EYA1-related disorder |
| RS2537297690 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS2537297705 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |
| RS2537297841 |
RAD21
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS2537299235 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS2537299697 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537300033 |
KIF1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS2537300215 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2537300700 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS2537306012 |
WASHC5
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 8, Ritscher-Schinzel syndrome |
| RS2537310121 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Blepharophimosis-impaired intellectual development syndrome, Blepharophimosis-impaired intellectual development syndrome |
| RS2537313097 |
GPAA1
|
Health Risk |
Likely pathogenic |
— |
| RS2537313187 |
WASHC5
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 8, Ritscher-Schinzel syndrome |
| RS2537314001 |
GPAA1
|
Health Risk |
Pathogenic |
— |
| RS2537315172 |
GPAA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2537316091 |
GPAA1
|
Health Risk |
Pathogenic |
— |
| RS2537316101 |
GPAA1
|
Health Risk |
Likely pathogenic |
— |
| RS2537316260 |
GPAA1
|
Health Risk |
Pathogenic |
— |
| RS2537331772 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS2537335758 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2537336180 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2537344137 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS2537344600 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS2537347486 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS2537347573 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Blepharophimosis-impaired intellectual development syndrome, Blepharophimosis-impaired intellectual development syndrome |
| RS2537350339 |
WASHC5
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 8, Ritscher-Schinzel syndrome |
| RS2537351091 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537351314 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537351663 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537351958 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS2537352053 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS2537363604 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS2537368449 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |